Rio de Janeiro: Editora Civilização, 2002.
References
Further reading
Rutherford, Laurie, "What's in a name? , The Chicago Tribune, 18 February 2002
Horn, Jeff, "A great book on public speaking? , Seattle Post-Intelligencer, 29 January 2002
External links
Official Site
Category:1927 births
Category:20th-century American non-fiction writers
Category:20th-century American male writers
Category:American male non-fiction writers
Category:American political writers
Category:American male writers
Category:American speechwriters
Category:University of Chicago alumni
Category:University of Chicago Divinity School alumni
Category:Writers from Chicago
Category:People from Trussville, Alabama
Category:Living peopleAntimicrobial testing of maternal and newborn specimens.
The American College of Obstetricians and Gynecologists (ACOG) Clinical Guideline for the Management of Patients with Intrapartum Maternal Sepsis provides guidance regarding the use of antimicrobial agents in the treatment of maternal sepsis, but does not address their usefulness in the newborn. Two experimental models were used to evaluate antimicrobial activity against common pathogens frequently encountered in the newborn. Initial testing involved isolates from intrapartum patients, while later assays were done with isolates from neonates treated for neonatal sepsis. Initial evaluation of the isolates from intrapartum patients revealed that ampicillin, amoxicillin, cefazolin, piperacillin/tazobactam, and vancomycin were the most active drugs against Enterobacteriaceae. Testing of the neonatal isolates revealed that ampicillin, amoxicillin, cefazolin, piperacillin/tazobactam, and vancomycin were most active against Enterobacteriaceae, while cefotaxime and ceftazidime were most effective against nonfermenting gram-negative rods. Based on these data, ampicillin and amoxicillin appear to be most appropriate agents for initial treatment of intrapartum patients with suspected or confirmed Gram-negative infections. Ampicillin can be used for initial treatment of patients with suspected or proven Gram-positive infections. Ceftazidime can be considered as an alternative to cefotaxime for the initial treatment of neonatal sepsis.Q:
Why be359ba680
Related links: